Scholarly Index
Joyce O’Shaughnessy
Baylor University Medical Center; 25,035 total citations; 370 total publications; best world rank #42
Baylor University Medical Center
25,035Total citations
370Total publications
60H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Treatment and Pharmacology | Lifetime | 299 | US 167 | 99.09 |
| Breast Cancer Treatment Studies | Lifetime | 286 | US 144 | 99.06 |
| Advanced Breast Cancer Therapies | Lifetime | 117 | US 56 | 98.94 |
| HER2/EGFR in Cancer Research | Lifetime | 279 | US 131 | 98.79 |
| PARP inhibition in cancer therapy | Lifetime | 803 | US 340 | 92.08 |
| Chemotherapy-related skin toxicity | Lifetime | 705 | US 325 | 83.17 |
| Breast Cancer Treatment Studies | 2021-2025 | 51 | US 20 | 99.28 |
| Advanced Breast Cancer Therapies | 2021-2025 | 42 | US 18 | 99.20 |
| Cancer Treatment and Pharmacology | 2021-2025 | 48 | US 18 | 98.95 |
| HER2/EGFR in Cancer Research | 2021-2025 | 51 | US 20 | 99.15 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 901 | US 331 | 96.53 |
| Cancer-related Molecular Pathways | 2021-2025 | 104 | US 46 | 93.46 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 880 | US 278 | 89.55 |